Journal of Neurodegenerative Diseases最新文献_第2页

Nicotine-Cadmium Interaction Alters Exploratory Motor Function and Increased Anxiety in Adult Male Mice. 尼古丁-镉相互作用改变成年雄性小鼠的探索性运动功能和焦虑增加。

Journal of Neurodegenerative Diseases Pub Date : 2014-01-01 Epub Date: 2014-11-12 DOI: 10.1155/2014/359436

Duyilemi Chris Ajonijebu, Philip Adeyemi Adeniyi, Adeshina Oloruntoba Adekeye, Babawale Peter Olatunji, Azeez Olakunle Ishola, Olalekan Michael Ogundele

{"title":"Nicotine-Cadmium Interaction Alters Exploratory Motor Function and Increased Anxiety in Adult Male Mice.","authors":"Duyilemi Chris Ajonijebu, Philip Adeyemi Adeniyi, Adeshina Oloruntoba Adekeye, Babawale Peter Olatunji, Azeez Olakunle Ishola, Olalekan Michael Ogundele","doi":"10.1155/2014/359436","DOIUrl":"https://doi.org/10.1155/2014/359436","url":null,"abstract":"In this study we evaluated the time dependence in cadmium-nicotine interaction and its effect on motor function, anxiety linked behavioural changes, serum electrolytes, and weight after acute and chronic treatment in adult male mice. Animals were separated randomly into four groups of n = 6 animals each. Treatment was done with nicotine, cadmium, or nicotine-cadmium for 21 days. A fourth group received normal saline for the same duration (control). Average weight was determined at 7-day interval for the acute (D1-D7) and chronic (D7-D21) treatment phases. Similarly, the behavioural tests for exploratory motor function (open field test) and anxiety were evaluated. Serum electrolytes were measured after the chronic phase. Nicotine, cadmium, and nicotine-cadmium treatments caused no significant change in body weight after the acute phase while cadmium-nicotine and cadmium caused a decline in weight after the chronic phase. This suggests the role of cadmium in the weight loss observed in tobacco smoke users. Both nicotine and cadmium raised serum Ca(2+) concentration and had no significant effect on K(+) ion when compared with the control. In addition, nicotine-cadmium treatment increased bioaccumulation of Cd(2+) in the serum which corresponded to a decrease in body weight, motor function, and an increase in anxiety. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2014 ","pages":"359436"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/359436","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34026648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains. 死后亨廷顿氏病和帕金森病人脑突触后密度蛋白的差异变化

Journal of Neurodegenerative Diseases Pub Date : 2014-01-01 Epub Date: 2014-01-16 DOI: 10.1155/2014/938530

C Fourie, E Kim, H Waldvogel, J M Wong, A McGregor, R L M Faull, J M Montgomery

{"title":"Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains.","authors":"C Fourie, E Kim, H Waldvogel, J M Wong, A McGregor, R L M Faull, J M Montgomery","doi":"10.1155/2014/938530","DOIUrl":"https://doi.org/10.1155/2014/938530","url":null,"abstract":"NMDA and AMPA-type glutamate receptors and their bound membrane-associated guanylate kinases (MAGUKs) are critical for synapse development and plasticity. We hypothesised that these proteins may play a role in the changes in synapse function that occur in Huntington's disease (HD) and Parkinson's disease (PD). We performed immunohistochemical analysis of human postmortem brain tissue to examine changes in the expression of SAP97, PSD-95, GluA2 and GluN1 in human control, and HD- and PD-affected hippocampus and striatum. Significant increases in SAP97 and PSD-95 were observed in the HD and PD hippocampus, and PSD95 was downregulated in HD striatum. We observed a significant increase in GluN1 in the HD hippocampus and a decrease in GluA2 in HD and PD striatum. Parallel immunohistochemistry experiments in the YAC128 mouse model of HD showed no change in the expression levels of these synaptic proteins. Our human data show that major but different changes occur in glutamatergic proteins in HD versus PD human brains. Moreover, the changes in human HD brains differ from those occurring in the YAC128 HD mouse model, suggesting that unique changes occur at a subcellular level in the HD human hippocampus. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2014 ","pages":"938530"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/938530","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34026651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 41

Multidisciplinary Interventions in Motor Neuron Disease. 运动神经元疾病的多学科干预。

Journal of Neurodegenerative Diseases Pub Date : 2014-01-01 Epub Date: 2014-11-18 DOI: 10.1155/2014/435164

U E Williams, E E Philip-Ephraim, S K Oparah

引用次数: 0

Prevalence and Cognitive Bases of Subjective Memory Complaints in Older Adults: Evidence from a Community Sample. 老年人主观记忆抱怨的患病率和认知基础:来自社区样本的证据。

Journal of Neurodegenerative Diseases Pub Date : 2014-01-01 Epub Date: 2014-04-27 DOI: 10.1155/2014/176843

Thomas Fritsch, McKee J McClendon, Maggie S Wallendal, Trevor F Hyde, Janet D Larsen

{"title":"Prevalence and Cognitive Bases of Subjective Memory Complaints in Older Adults: Evidence from a Community Sample.","authors":"Thomas Fritsch, McKee J McClendon, Maggie S Wallendal, Trevor F Hyde, Janet D Larsen","doi":"10.1155/2014/176843","DOIUrl":"https://doi.org/10.1155/2014/176843","url":null,"abstract":"Objectives. To estimate the prevalence of subjective memory complaints (SMCs) in a sample of community-dwelling, older adults and to examine cognitive bases of these complaints. Participants. 499 community-dwelling adults, 65 and older. Measurements. A telephone survey consisting of cognitive tests and clinical and sociodemographic variables. SMCs were based on subjects' evaluations and subjects' perceptions of others' evaluations. Analysis. Logistic regression was used to model the risk for SMCs as a function of the cognitive, clinical, and sociodemographic variables. We tested for interactions of the cognitive variables with age, education, and gender. Results. 27.1% reported memory complaints. Among the younger age, better objective memory performance predicted lower risk for SMCs, while among the older age, better memory had no effect on risk. Among the better-educated people, better global cognitive functioning predicted lower risk for SMCs, while among the less-educated people, better global cognitive functioning had no effect on SMC risk. When predicting others' perceptions, better objective memory was associated with lower risk for SMCs. Conclusion. Objective memory performance and global cognitive functioning are associated with lower risk for SMCs, but these relationships are the strongest for the younger age and those with more education, respectively. Age and education may affect the ability to accurately appraise cognitive functioning. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2014 ","pages":"176843"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/176843","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34129121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 44

Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment. 临床诊断环境下肌强直性营养不良1型基因的简单重复引物PCR分析。

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2013-11-11 DOI: 10.1155/2013/857564

Philippa A Dryland, Elaine Doherty, Jennifer M Love, Donald R Love

{"title":"Simple Repeat-Primed PCR Analysis of the Myotonic Dystrophy Type 1 Gene in a Clinical Diagnostics Environment.","authors":"Philippa A Dryland, Elaine Doherty, Jennifer M Love, Donald R Love","doi":"10.1155/2013/857564","DOIUrl":"https://doi.org/10.1155/2013/857564","url":null,"abstract":"Myotonic dystrophy type 1 is an autosomal dominant neuromuscular disorder that is caused by the expansion of a CTG trinucleotide repeat in the DMPK gene. The confirmation of a clinical diagnosis of DM-1 usually involves PCR amplification of the CTG repeat-containing region and subsequent sizing of the amplification products in order to deduce the number of CTG repeats. In the case of repeat hyperexpansions, Southern blotting is also used; however, the latter has largely been superseded by triplet repeat-primed PCR (TP-PCR), which does not yield a CTG repeat number but nevertheless provides a means of stratifying patients regarding their disease severity. We report here a combination of forward and reverse TP-PCR primers that allows for the simple and effective scoring of both the size of smaller alleles and the presence or absence of expanded repeat sequences. In addition, the CTG repeat-containing TP-PCR forward primer can target both the DM-1 and Huntington disease genes, thereby streamlining the work flow for confirmation of clinical diagnoses in a diagnostic laboratory. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"857564"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34129117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

Bacopa monnieri Phytochemicals Mediated Synthesis of Platinum Nanoparticles and Its Neurorescue Effect on 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Experimental Parkinsonism in Zebrafish. 假马齿苋植物化学物质介导的铂纳米颗粒合成及其对1-甲基4-苯基1,2,3,6四氢吡啶诱导的斑马鱼实验性帕金森病的神经修复作用

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2013-03-04 DOI: 10.1155/2013/972391

Jayshree Nellore, Cynthia Pauline, Kanchana Amarnath

{"title":"Bacopa monnieri Phytochemicals Mediated Synthesis of Platinum Nanoparticles and Its Neurorescue Effect on 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Experimental Parkinsonism in Zebrafish.","authors":"Jayshree Nellore, Cynthia Pauline, Kanchana Amarnath","doi":"10.1155/2013/972391","DOIUrl":"https://doi.org/10.1155/2013/972391","url":null,"abstract":"Current discovery demonstrates the rapid formation of platinum nanoparticles using leaf extract of a neurobeneficial plant, Bacopa monnieri (BmE). The nanoparticles (BmE-PtNPs) were stabilized and then coated with varied phytochemicals present within the leaf extract. These nanoparticles demonstrated the same activity of Complex I, as that of oxidizing NADH to NAD(+) using a spectrophotometric method. This suggests that BmE-PtNPs are a potential medicinal substance for oxidative stress mediated disease with suppressed mitochondrial complex I, namely, Parkinson's disease (PD). Hence, the neuroprotective potentials of the phytochemical coated nanoparticle were explored in 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine- (MPTP-)induced experimental Parkinsonism in zebrafish model. BmE-PtNPs pretreatment significantly reversed toxic effects of MPTP by increasing the levels of dopamine, its metabolites, GSH and activities of GPx, catalase, SOD and complex I, and reducing levels of MDA along with enhanced locomotor activity. Taken together, these findings suggest that BmE-PtNPs have protective effect in MPTP-induced neurotoxicity in this model of Parkinson's disease via their dual functions as mitochondrial complex I and antioxidant activity. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"972391"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/972391","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34129120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 72

The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease. 硫辛酸治疗对阿尔茨海默病患者认知功能的影响。

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2013-03-30 DOI: 10.1155/2013/454253

Antonietta Fava, Domenico Pirritano, Massimiliano Plastino, Dario Cristiano, Giovanna Puccio, Carmen Colica, Caterina Ermio, Matteo De Bartolo, Gaetano Mauro, Domenico Bosco

{"title":"The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease.","authors":"Antonietta Fava, Domenico Pirritano, Massimiliano Plastino, Dario Cristiano, Giovanna Puccio, Carmen Colica, Caterina Ermio, Matteo De Bartolo, Gaetano Mauro, Domenico Bosco","doi":"10.1155/2013/454253","DOIUrl":"10.1155/2013/454253","url":null,"abstract":"Diabetes mellitus (DM) is an important risk factor for Alzheimer's disease (AD). Most diabetic patients have insulin resistance (IR) that is associated with compensatory hyperinsulinemia, one of the mechanisms suggested for increased AD risk in patients with DM. Alpha-lipoic acid (ALA) is a disulfide molecule with antioxidant properties that has positive effects on glucose metabolism and IR. This study evaluated the effect of ALA treatment (600 mg/day) on cognitive performances in AD patients with and without DM. One hundred and twenty-six patients with AD were divided into two groups, according to DM presence (group A) or absence (group B). Cognitive functions were assessed by MMSE, Alzheimer's Disease Assessment Scale-cognitive (ADAS-Cog), Clinician's Interview-Based Impression of Severity (CIBIC), Clinical Dementia Rating (CDR), and Alzheimer's Disease Functional and Change Scale (ADFACS). IR was assessed by HOMA index. At the end of the study, MMSE scores showed a significant improvement in 43% patients of group A (26 subjects) and 23% of group B (15 subjects), compared to baseline (P = .001). Also ADAS-Cog, CIBIC, and ADFACS scores showed a significant improvement in group A versus group B. IR was higher in group A. Our study suggests that ALA therapy could be effective in slowing cognitive decline in patients with AD and IR. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"454253"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/454253","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33959371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 57

Amyloid Beta-Protein and Neural Network Dysfunction. 淀粉样蛋白与神经网络功能障碍。

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2013-01-30 DOI: 10.1155/2013/657470

Fernando Peña-Ortega

{"title":"Amyloid Beta-Protein and Neural Network Dysfunction.","authors":"Fernando Peña-Ortega","doi":"10.1155/2013/657470","DOIUrl":"https://doi.org/10.1155/2013/657470","url":null,"abstract":"Understanding the neural mechanisms underlying brain dysfunction induced by amyloid beta-protein (Aβ) represents one of the major challenges for Alzheimer's disease (AD) research. The most evident symptom of AD is a severe decline in cognition. Cognitive processes, as any other brain function, arise from the activity of specific cell assemblies of interconnected neurons that generate neural network dynamics based on their intrinsic and synaptic properties. Thus, the origin of Aβ-induced cognitive dysfunction, and possibly AD-related cognitive decline, must be found in specific alterations in properties of these cells and their consequences in neural network dynamics. The well-known relationship between AD and alterations in the activity of several neural networks is reflected in the slowing of the electroencephalographic (EEG) activity. Some features of the EEG slowing observed in AD, such as the diminished generation of different network oscillations, can be induced in vivo and in vitro upon Aβ application or by Aβ overproduction in transgenic models. This experimental approach offers the possibility to study the mechanisms involved in cognitive dysfunction produced by Aβ. This type of research may yield not only basic knowledge of neural network dysfunction associated with AD, but also novel options to treat this modern epidemic. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"657470"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/657470","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33959375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 30

Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions. 神经退行性疾病：多因素构象疾病及其治疗干预。

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2012-12-30 DOI: 10.1155/2013/563481

Saba Sheikh, Safia, Ejazul Haque, Snober S Mir

{"title":"Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions.","authors":"Saba Sheikh, Safia, Ejazul Haque, Snober S Mir","doi":"10.1155/2013/563481","DOIUrl":"10.1155/2013/563481","url":null,"abstract":"Neurodegenerative diseases are multifactorial debilitating disorders of the nervous system that affect approximately 30 millionindividuals worldwide. Neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis diseases are the consequence of misfolding and dysfunctional trafficking of proteins. Beside that, mitochondrial dysfunction, oxidative stress, and/or environmental factors strongly associated with age have also been implicated in causing neurodegeneration. After years of intensive research, considerable evidence has accumulated that demonstrates an important role of these factors in the etiology of common neurodegenerative diseases. Despite the extensive efforts that have attempted to define the molecular mechanisms underlying neurodegeneration, many aspects of these pathologies remain elusive. However, in order to explore the therapeutic interventions directed towards treatment of neurodegenerative diseases, neuroscientists are now fully exploiting the data obtained from studies of these basic mechanisms that have gone awry. The novelty of these mechanisms represents a challenge to the identification of viable drug targets and biomarkers for early diagnosis of the diseases. In this paper, we are reviewing various aspects associated with the disease and the recent trends that may have an application for the treatment of the neurodegenerative disorders. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"563481"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33959374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model. 从星形细胞-神经元乳酸穿梭模型的角度重新评估阿尔茨海默病的代谢。

Journal of Neurodegenerative Diseases Pub Date : 2013-01-01 Epub Date: 2013-04-23 DOI: 10.1155/2013/234572

Jordan T Newington, Richard A Harris, Robert C Cumming

{"title":"Reevaluating Metabolism in Alzheimer's Disease from the Perspective of the Astrocyte-Neuron Lactate Shuttle Model.","authors":"Jordan T Newington, Richard A Harris, Robert C Cumming","doi":"10.1155/2013/234572","DOIUrl":"https://doi.org/10.1155/2013/234572","url":null,"abstract":"The conventional view of central nervous system (CNS) metabolism is based on the assumption that glucose is the main fuel source for active neurons and is processed in an oxidative manner. However, since the early 1990s research has challenged the idea that the energy needs of nerve cells are met exclusively by glucose and oxidative metabolism. This alternative view of glucose utilization contends that astrocytes metabolize glucose to lactate, which is then released and taken up by nearby neurons and used as a fuel source, commonly known as the astrocyte-neuron lactate shuttle (ANLS) model. Once thought of as a waste metabolite, lactate has emerged as a central player in the maintenance of neuronal function and long-term memory. Decreased neuronal metabolism has traditionally been viewed as a hallmark feature of Alzheimer's disease (AD). However, a more complex picture of CNS metabolism is emerging that may provide valuable insight into the pathophysiological changes that occur during AD and other neurodegenerative diseases. This review will examine the ANLS model and present recent evidence highlighting the critical role that lactate plays in neuronal survival and memory. Moreover, the role of glucose and lactate metabolism in AD will be re-evaluated from the perspective of the ANLS. ","PeriodicalId":16405,"journal":{"name":"Journal of Neurodegenerative Diseases","volume":"2013 ","pages":"234572"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/234572","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33957294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 82